A detailed history of Great West Life Assurance CO transactions in Macrogenics Inc stock. As of the latest transaction made, Great West Life Assurance CO holds 3,508 shares of MGNX stock, worth $14,733. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,508
Holding current value
$14,733
% of portfolio
0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$9.77 - $21.47 $34,273 - $75,316
3,508 New
3,508 $52,000
Q3 2022

Nov 01, 2022

BUY
$3.01 - $5.22 $41,610 - $72,161
13,824 Added 446.66%
16,919 $59,000
Q2 2022

Aug 12, 2022

BUY
$2.25 - $9.99 $6,963 - $30,919
3,095 New
3,095 $9,000
Q2 2022

Aug 09, 2022

SELL
$2.25 - $9.99 $6,498 - $28,851
-2,888 Closed
0 $0
Q1 2022

May 12, 2022

BUY
$8.12 - $16.9 $1,729 - $3,599
213 Added 7.96%
2,888 $27,000
Q4 2021

Feb 14, 2022

BUY
$15.91 - $21.88 $3,197 - $4,397
201 Added 8.12%
2,675 $43,000
Q2 2021

Aug 11, 2021

SELL
$20.49 - $35.63 $16,166 - $28,112
-789 Reduced 24.18%
2,474 $66,000
Q3 2020

Nov 17, 2020

SELL
$24.69 - $31.6 $595,448 - $762,097
-24,117 Reduced 88.08%
3,263 $82,000
Q3 2020

Nov 13, 2020

BUY
$24.69 - $31.6 $595,448 - $762,097
24,117 Added 739.11%
27,380 $689,000
Q4 2019

Feb 11, 2020

BUY
$7.95 - $12.27 $25,940 - $40,037
3,263 New
3,263 $35,000
Q3 2019

Oct 25, 2019

SELL
$12.44 - $17.48 $77,314 - $108,638
-6,215 Closed
0 $0
Q4 2018

Feb 12, 2019

BUY
$11.75 - $21.42 $43,651 - $79,575
3,715 Added 148.6%
6,215 $76,000
Q3 2017

Nov 09, 2017

BUY
$15.52 - $18.94 $38,800 - $47,350
2,500
2,500 $46,000

Others Institutions Holding MGNX

About MACROGENICS INC


  • Ticker MGNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,458,800
  • Market Cap $258M
  • Description
  • MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...
More about MGNX
Track This Portfolio

Track Great West Life Assurance CO Portfolio

Follow Great West Life Assurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.